Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
For KTRs meeting NCEP-ATP-III criteria with fourth-quartile 25(OH)D, there were 1.5 new diagnoses per 100 patient-years versus 4.2 events per 100 patient-years in KTRs with first-quartile 25(OH)D (P < 0.001).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
In this study, patients were classified as having MetS on the basis of the National Cholesterol Education Program, Adult Treatment Panel III (NCEP-ATP-III) definition.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Association between Post-Transplant Vitamin D, Metabolic Syndrome, and Post-Transplant Diabetes Mellitus
Study design awaiting verification · Kidney360 · 2025
Original publication title
Association between Post-Transplant Vitamin D, Metabolic Syndrome, and Post-Transplant Diabetes Mellitus
Copyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Associations between 25-hydroxyvitamin D (25(OH)D) deficiency and diabetes have been observed in the general population, but are less delineated in kidney transplant recipients (KTRs), especially in the context of highly prevalent metabolic syndrome (MetS) features in KTRs. We hypothesized that vitamin D deficiency may present greater risk in KTRs with greater burden of MetS features.
Source: BackgroundAbstract: What methods does the paper describe?
We retrospectively evaluated 1792 KTRs with no treated diabetes at transplant between 1998 and 2018. Vitamin D was measured at ≥3 months post-transplant. MetS features were defined by the National Cholesterol Education Program, Adult Treatment Panel III (NCEP-ATP-III) criteria. The primary outcome was treated post-transplant diabetes mellitus (PTDM) incidence.
Source: MethodsAbstract: Key Points
Metabolic syndrome components after kidney transplant are associated with a higher likelihood of post-transplant diabetes.
This predictive association persists independently of other prediabetes markers, including fasting sugar and hemoglobin A1c.
Higher vitamin D-25 levels blunt this association; in patients with high metabolic syndrome burden, vitamin D supplementation may be warranted.
Abstract: Results
In 1792 nondiabetic KTRs followed for 10,956 patient-years, 237 patients developed PTDM. For KTRs meeting NCEP-ATP-III criteria with fourth-quartile 25(OH)D, there were 1.5 new diagnoses per 100 patient-years versus 4.2 events per 100 patient-years in KTRs with first-quartile 25(OH)D (P < 0.001). In multivariate survival regression, vitamin D was, accounting for individual NCEP-ATP-III criteria, associated with PTDM (hazard ratio, 0.93 per 10 nmol/ml 25(OH)D, P = 0.007) independently of fasting blood sugar and hemoglobin A1c. In marginal effects analysis, MetS effect on PTDM increased as serum 25(OH)D levels decreased.
Source: ResultsAbstract: Conclusions
Our study suggests that decreased 25(OH)D is associated with increased PTDM, and this marginal effect worsens as KTRs have an increased burden of MetS.
Source: ConclusionsAuthors’ abstract
Key Points
Metabolic syndrome components after kidney transplant are associated with a higher likelihood of post-transplant diabetes.
This predictive association persists independently of other prediabetes markers, including fasting sugar and hemoglobin A1c.
Higher vitamin D-25 levels blunt this association; in patients with high metabolic syndrome burden, vitamin D supplementation may be warranted.
Background
Associations between 25-hydroxyvitamin D (25(OH)D) deficiency and diabetes have been observed in the general population, but are less delineated in kidney transplant recipients (KTRs), especially in the context of highly prevalent metabolic syndrome (MetS) features in KTRs. We hypothesized that vitamin D deficiency may present greater risk in KTRs with greater burden of MetS features.
Methods
We retrospectively evaluated 1792 KTRs with no treated diabetes at transplant between 1998 and 2018. Vitamin D was measured at ≥3 months post-transplant. MetS features were defined by the National Cholesterol Education Program, Adult Treatment Panel III (NCEP-ATP-III) criteria. The primary outcome was treated post-transplant diabetes mellitus (PTDM) incidence.
Results
In 1792 nondiabetic KTRs followed for 10,956 patient-years, 237 patients developed PTDM. For KTRs meeting NCEP-ATP-III criteria with fourth-quartile 25(OH)D, there were 1.5 new diagnoses per 100 patient-years versus 4.2 events per 100 patient-years in KTRs with first-quartile 25(OH)D (P < 0.001). In multivariate survival regression, vitamin D was, accounting for individual NCEP-ATP-III criteria, associated with PTDM (hazard ratio, 0.93 per 10 nmol/ml 25(OH)D, P = 0.007) independently of fasting blood sugar and hemoglobin A1c. In marginal effects analysis, MetS effect on PTDM increased as serum 25(OH)D levels decreased.
Conclusions
Our study suggests that decreased 25(OH)D is associated with increased PTDM, and this marginal effect worsens as KTRs have an increased burden of MetS.
Publication and source details
Original title: Association between Post-Transplant Vitamin D, Metabolic Syndrome, and Post-Transplant Diabetes Mellitus
Rohit Malyala; Karan Vansjalia; Michelle Nash; Niki Dacouris; Lindita Rapi; G.V. Ramesh Prasad
Kidney360 · 2025
Correspondence: Dr. Rohit Malyala, email: rohit.malyala@alumni.ubc.caCopyright © 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology2025https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T02:37:55.641185+00:00
DOI: 10.34067/kid.0000000763 · PMC12338344